To further elucidate changes in systemic and local metabolism in PyMT-RIDad mice, we conducted a comprehensive evaluation of metabolic parameters, including systemic glucose tolerance, insulin sensitivity, lipid clearance, and triolein uptake, while monitoring tumor development (Figure 5C). The gene discussed is INS; the disease is neoplasm.